0001209191-18-017778.txt : 20180307
0001209191-18-017778.hdr.sgml : 20180307
20180307175434
ACCESSION NUMBER: 0001209191-18-017778
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180306
FILED AS OF DATE: 20180307
DATE AS OF CHANGE: 20180307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hassig Christian
CENTRAL INDEX KEY: 0001730657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 18674378
MAIL ADDRESS:
STREET 1: C/O SIERRA ONCOLOGY, INC.
STREET 2: 885 W. GEORGIA ST., #2150
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sierra Oncology, Inc.
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
FORMER COMPANY:
FORMER CONFORMED NAME: ProNAi Therapeutics Inc
DATE OF NAME CHANGE: 20040513
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-06
0
0001290149
Sierra Oncology, Inc.
SRRA
0001730657
Hassig Christian
C/O SIERRA ONCOLOGY, INC.
2150-885 WEST GEORGIA ST.
VANCOUVER
A1
V6C 3E8
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Scientific Officer
Stock Option (right to buy)
2.36
2018-03-06
4
A
0
205180
0.00
A
2028-03-06
Common Stock
205180
205180
D
The option vests as to 25% of the total shares on January 1, 2019, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on January 1, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Sukhi Jagpal as attorney-in-fact for Christian Hassig, Ph.D.
2018-03-07